AddLife AB
STO:ALIF B
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
94.4117
168
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
AddLife AB
AddLife AB
Operating Income
AddLife AB
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AddLife AB
STO:ALIF B
|
Operating Income
kr805m
|
CAGR 3-Years
5%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
BICO Group AB
STO:BICO
|
Operating Income
-kr100m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biotage AB
STO:BIOT
|
Operating Income
kr351m
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
22%
|
|
|
G
|
Genovis AB
STO:GENO
|
Operating Income
kr23.2m
|
CAGR 3-Years
41%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
MedCap AB (publ)
STO:MCAP
|
Operating Income
kr294.3m
|
CAGR 3-Years
38%
|
CAGR 5-Years
33%
|
CAGR 10-Years
32%
|
|
|
M
|
Magle Chemoswed Holding AB
STO:MAGLE
|
Operating Income
kr21.7m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AddLife AB
Glance View
AddLife AB, a prominent player in the life sciences sector, intricately weaves its narrative through a commitment to enhancing healthcare and laboratory services across Europe. Founded in Sweden, the company has established itself as a crucial intermediary, effectively bridging the gap between manufacturers of medical devices and the healthcare institutions that require them. AddLife operates by acquiring and developing niche companies within two core segments: Labtech and Medtech. Through Labtech, it supplies essential equipment, instruments, and consumables for diagnostic and research laboratories. In Medtech, it provides a variety of healthcare logistics, medical products, and services to hospitals and care facilities, enhancing their operational efficiencies. The financial heartbeat of AddLife rests on its adeptness at creating value through strategic acquisitions and organic growth, capitalizing on the increasing demand for innovative healthcare solutions. By continuously expanding its product portfolio and enhancing the capabilities of its subsidiaries, AddLife ensures a diversified revenue stream, mitigating risks associated with dependence on any single product or market. This approach not only fortifies their market position but also fuels their profit margins, as they deftly respond to shifting industry demands and regulatory changes. The company's shared values and decentralized business model promote entrepreneurship within its subsidiaries, fostering an environment where innovation can thrive—ensuring their continued success and substantial contribution to the evolving landscape of healthcare.
See Also
What is AddLife AB's Operating Income?
Operating Income
805m
SEK
Based on the financial report for Dec 31, 2023, AddLife AB's Operating Income amounts to 805m SEK.
What is AddLife AB's Operating Income growth rate?
Operating Income CAGR 5Y
36%
Over the last year, the Operating Income growth was -4%. The average annual Operating Income growth rates for AddLife AB have been 5% over the past three years , 36% over the past five years .
You don't have any saved screeners yet
